A Prospective Study to Evaluate Continuous Positive Airway Pressure Devices to Reduce Pulmonary Dose
Data collection and assessment on patients with left-sided breast cancer or undergoing lung stereotactic body radiation therapy (SBRT) utilizing continuous positive airway pressure (CPAP) devices.
Checked against the public recordLast updated Feb 2, 2026 · Source: ClinicalTrials.gov
What this study is about
- Purpose
- Supportive Care
- Study type
- Interventional
- Phase
- Not applicable
- Sponsor
- Case Comprehensive Cancer Center
- Interventions being studied
- Device: Continuous Positive Airway Pressure; Other: Deep inspiratory breath hold; Other: Free Breath
How this study is categorized
These labels come from structured fields and exact terms in the public record.
Who may be able to participate
Inclusion Criteria: * Patients with left-sided breast cancers * Patients must be undergoing left breast/chest wall radiation with or without regional nodal irradiation * Patients undergoing lung SBRT * Primary lung cancers * Metastatic lung tumors Exclusion Criteria: * Patients with right side breast cancer * Patients who are unable to tolerate the CPAP device
Important: This is the sponsor’s public criteria, not a determination of eligibility. The study team must review your individual situation.
U.S. locations
- Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer CenterCleveland, Ohio
Source and freshness
Processed from ClinicalTrials.gov. Last public update: Feb 2, 2026. Always confirm current availability with the study team.